Your browser doesn't support javascript.
loading
rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs.
Spirig, Rolf; Campbell, Ian K; Koernig, Sandra; Chen, Chao-Guang; Lewis, Bonnie J B; Butcher, Rebecca; Muir, Ineke; Taylor, Shirley; Chia, Jenny; Leong, David; Simmonds, Jason; Scotney, Pierre; Schmidt, Peter; Fabri, Louis; Hofmann, Andreas; Jordi, Monika; Spycher, Martin O; Cattepoel, Susann; Brasseit, Jennifer; Panousis, Con; Rowe, Tony; Branch, Donald R; Baz Morelli, Adriana; Käsermann, Fabian; Zuercher, Adrian W.
Afiliación
  • Spirig R; CSL Behring AG, 3010 Bern, Switzerland; adrian.zuercher@cslbehring.com rolf.spirig@cslbehring.com.
  • Campbell IK; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Koernig S; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Chen CG; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Lewis BJB; Centre for Innovation Canadian Blood Services, Toronto, Ontario K1G 4J5, Canada; and.
  • Butcher R; Department of Medicine, University of Toronto, Toronto, Ontario M5G 2M1, Canada.
  • Muir I; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Taylor S; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Chia J; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Leong D; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Simmonds J; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Scotney P; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Schmidt P; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Fabri L; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Hofmann A; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Jordi M; CSL Behring AG, 3010 Bern, Switzerland.
  • Spycher MO; CSL Behring AG, 3010 Bern, Switzerland.
  • Cattepoel S; CSL Behring AG, 3010 Bern, Switzerland.
  • Brasseit J; CSL Behring AG, 3010 Bern, Switzerland.
  • Panousis C; CSL Behring AG, 3010 Bern, Switzerland.
  • Rowe T; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Branch DR; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
  • Baz Morelli A; Centre for Innovation Canadian Blood Services, Toronto, Ontario K1G 4J5, Canada; and.
  • Käsermann F; Department of Medicine, University of Toronto, Toronto, Ontario M5G 2M1, Canada.
  • Zuercher AW; CSL Ltd., Bio21 Institute, Parkville, Victoria 3010, Australia.
J Immunol ; 200(8): 2542-2553, 2018 04 15.
Article en En | MEDLINE | ID: mdl-29531170
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Proteínas del Sistema Complemento / Inmunoglobulina G / Fragmentos Fc de Inmunoglobulinas / Receptores Fc / Anticuerpos Monoclonales / Complejo Antígeno-Anticuerpo Límite: Animals / Humans / Male Idioma: En Revista: J Immunol Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Proteínas del Sistema Complemento / Inmunoglobulina G / Fragmentos Fc de Inmunoglobulinas / Receptores Fc / Anticuerpos Monoclonales / Complejo Antígeno-Anticuerpo Límite: Animals / Humans / Male Idioma: En Revista: J Immunol Año: 2018 Tipo del documento: Article